Renibus Therapeutics Announces Publication of a Novel Stress Test for Assessing Antioxidant Defenses in Chronic Kidney Disease
16 juin 2020 09h00 HE
|
Rénibus Therapeutics Inc.
DALLAS, Texas, June 16, 2020 (GLOBE NEWSWIRE) -- Renibus Therapeutics, Inc., a clinical stage biotechnology company developing novel therapies for prevention and treatment of kidney diseases, today...